Brendan Smith
Net worth: 427 164 $ as of 2024-02-28
Profile
Currently, Brendan Smith holds the position of Senior VP, Chief Financial & Accounting Officer at CRISPR Therapeutics AG. In the past Mr. Smith was Chief Financial Officer & Head-Corporate Strategy at Translate Bio, Inc. and Partner & Associate Director at The Boston Consulting Group, Inc. He received an undergraduate degree from Worcester Polytechnic Institute and an MBA from Harvard Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CRISPR THERAPEUTICS AG
0.01% | 2023-03-30 | 5,072 ( 0.01% ) | 427 164 $ | 2024-02-28 |
Former positions of Brendan Smith
Companies | Position | End |
---|---|---|
CRISPR THERAPEUTICS AG | Director of Finance/CFO | 2023-03-13 |
TRANSLATE BIO, INC. | Director of Finance/CFO | 2021-09-13 |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Corporate Officer/Principal | 2021-02-28 |
Pfizer AG | Director/Board Member | - |
Training of Brendan Smith
Worcester Polytechnic Institute | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
Private companies | 3 |
---|---|
Translate Bio, Inc.
Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Pfizer AG |